Inspection Record

Brookfield Medical/Surgical Supply, Inc. — FDA 483 Findings

US FDAInspected 2018-12-21Published 2019-04-30 8 findingsAseptic processing and sterility assuranceEquipment and facilityProcess validationMaterial and supplier controlOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.

2Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purport ing to be sterile are not followed.

3Equipment and facility

Equipment and utensils are not maintained at appropriate intervals to prevent malfunctions that would alter the safety, identity, strength, quality or purity of the drug product.

4Process validation

There are no written procedures for production and process controls designed to assure that the chug products have the identity, strength, quality, and purity they purport or are represented to possess.

5Material and supplier control

Each lot of a component that is liable to microbiological contamination that is objectionable in view of its intended use is not subjected to microbiological tests before use.

6Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

7Other quality system

The firm has failed to collect retain samples for any of the finished drug products (Triamcinolone Acetonide, Methylprednisolone Acetate and Betamethasone Sodium Phosphate) that have been manufactured since the firm began operations in 2015.

8Other quality system

You compound drugs that are essentially a copy of one or more approved drugs within the meaning of sections 503B(a)(5) and 503B(d)(2).

About this record

Extracted automatically from the document US FDA published on 2019-04-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Brookfield Medical/Surgical Supply, Inc. company profile — full history US FDA documents, 2019 Go to Findings search